January 5, 2018 / 2:16 PM / 9 months ago

BRIEF-Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook

Jan 5 (Reuters) - Diplomat Pharmacy Inc:

* - EXPECTS 2017 REVENUE TO BE NEAR MIDDLE OF PREVIOUSLY PROVIDED RANGE

* FY2018 EARNINGS PER SHARE VIEW $0.95, REVENUE VIEW $5.38 BILLION -- THOMSON REUTERS I/B/E/S

* DIPLOMAT REAFFIRMS 2017 GUIDANCE, PROVIDES PRELIMINARY 2018 OUTLOOK

* SEES FY 2018 REVENUE $5.3 BILLION TO $5.6 BILLION

* - IN 2018, EXPECTS ADJUSTED EBITDA IN RANGE OF $164 TO $170 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below